Depression Clinical Trials in Chicago, IL

Depression Clinical Trials in Chicago, IL

View the best 10 depression medical studies in Chicago, Illinois. Access promising new therapies by applying to a Chicago-based Depression clinical trial.

Trials in Chicago, Illinois

Here are the top 10 medical studies for depression in Chicago, Illinois

Image of Department of Medicine, Vitoux Program on Aging and Prevention in Chicago, United States.

Lumen Coached PST Intervention +1 More

Behavioural Intervention

Recruiting0 awards
This trial studies ways to help people with mild-to-moderate depression/anxiety improve their emotional health via 8 coaching sessions.
Image of University of Illinois at Chicago, Division of Specialized Care for Children in Chicago, United States.

Adapted Coping with Depression-Adolescent +5 More

Behavioural Intervention

Recruiting1 award
This trial is testing a combined mental health treatment and care coordination program for youth with disabilities to see if it helps them cope better with anxiety, depression, and manage their health better. 780 youth in Illinois will be randomly placed in either the combined program or care coordination alone.
Image of Ann & Robert H. Lurie Children's Hospital of Chicago in Chicago, United States.

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Behavioral Intervention

Recruiting1 award2 criteria
This trial aims to prevent depression in at-risk teenagers using the CATCH-IT program. The program teaches skills to manage thoughts, behaviors, and relationships through various therapies. The goal is to make the program effective, easy to use, and widely available. CATCH-IT is an online depression prevention intervention that has been tested in various studies for its effectiveness in preventing depressive episodes among adolescents.
Image of Advanced Research Center /ID# 227073 in Anaheim, United States.

Placebo +1 More

Pharmacotherapy

Recruiting1 awardPhase 3
This trial is testing the safety and effectiveness of Cariprazine for treating depressive episodes in children and teenagers with bipolar I disorder. The goal is to find out if Cariprazine can help young people with this condition. Cariprazine is an atypical antipsychotic recently approved for the treatment of depressive episodes in adults with bipolar I disorder.
Image of Northwestern University in Chicago, United States.

My Wellbeing Guide

Behavioral Intervention

Recruiting1 award
This trial will compare the effects of the intervention on depressive symptoms in patients with cancer over time.
Image of Anderson Clinical Research in Redlands, United States.

Placebo

Verified
Recruiting0 awardsPhase 2 & 3
A Phase 2/3 Trial is designed to evaluate SEP-363856 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder
Image of University of Chicago in Chicago, United States.

Psilocybin

Psychedelic

Recruiting1 awardPhase 2
This trial tests psilocybin, a compound from certain mushrooms, on adults with major depressive disorder and borderline personality disorder. It aims to see if psilocybin can improve mood and reduce symptoms by affecting brain chemicals. Psilocybin has shown promise as a treatment for major depressive disorder and has been designated as a breakthrough therapy by the FDA.
Image of Sheppard Pratt Health System in Baltimore, United States.

Psilocybin

Psychedelic

Recruiting1 awardPhase 3
This trial is testing a new medication called COMP360 to help people with severe depression that hasn't improved with other treatments. The study involves adults aged 18 and older. Researchers want to see if a single dose of COMP360 can reduce depression symptoms when given with psychological support.
Image of Neumora Investigative Site in Orlando, United States.

NMRA-335140

Recruiting2 awardsPhase 3
This trial is testing a new medication called NMRA-335140 to see if it helps people with major depressive disorder. It includes participants who have no safety concerns. The medication aims to improve mood by affecting brain chemicals.
Image of Pediatric Research in Office Settings National Headquarters in Itasca, United States.

Treatment as usual +1 More

Behavioral Intervention

Recruiting1 award
This trial aims to address the growing issue of suicidal thoughts and behaviors among teenagers. The study will test a digital suicide prevention intervention that can be used by pediatricians in primary care settings. If successful,

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.